In this study, we demonstrated the roles of circHIAT1/miR-19a-3p/CADM2 axis in modulating the EMT and drug resistance of Palbociclib in BC cells, and showed that quercetin can act as a potential bioactive compound to reverse Palbociclib resistance in BC treatment. The gene discussed is CADM2; the disease is breast cancer.